Saturday, September 6, 2008 - 9:51PM EST

Review Articles

1. Treatment options in the modern management of Parkinson disease.

Author
Schapira AH;
Institution
University Department of Clinical Neurosciences, Institute of Neurology, University College London, England. a.schapira@medsch.ucl.ac.uk
Journal
Arch Neurol. 2007 Aug;64(8):1083-8.

2. Chinese herbs and herbal extracts for neuroprotection of dopaminergic neurons and potential therapeutic treatment of Parkinson's disease.

Author
Chen LW; Wang YQ; Wei LC; Shi M; Chan YS;
Institution
Institute of Neurosciences, The Fourth Military Medical University, Xi'an 710032, PR China. lwchen@pub.xaonline.com
Journal
CNS Neurol Disord Drug Targets. 2007 Aug;6(4):273-81.
Abstract URL
Click here to view abstract

3. Gene therapy for Parkinson's disease.

Author
Mochizuki H;
Institution
Department of Neurology, Research Institute for Diseases of Old Age, Juntendo University, Hongo, Bunkyo, Tokyo, Japan. hideki@med.juntendo.ac.jp
Journal
Expert Rev Neurother. 2007 Aug;7(8):957-60.
Abstract URL
Click here to view abstract

4. Parkinson's disease.

Author
Clarke CE;
Institution
Department of Neurology, City Hospital, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham B18 7QH.
Journal
BMJ. 2007 Sep 1;335(7617):441-5.

5. Management of non-motor symptoms in advanced Parkinson disease.

Author
Truong DD; Bhidayasiri R; Wolters E;
Institution
The Parkinson's and Movement Disorder Institute, 9940 Talbert Avenue, Fountain Valley, CA 92708, USA. dtruong@pmdi.org
Journal
J Neurol Sci. 2008 Mar 15;266(1-2):216-28. Epub 2007 Sep 4.
Abstract URL
Click here to view abstract

6. Apomorphine therapy in Parkinson's disease: a review.

Author
Haq IU; Lewitt PA; Fernandez HH;
Institution
Movement Disorders Program, University of Florida, Department of Neurology/McKnight Brain Institute, 100 S. Newell Drive, PO Box 100236, Gainesville, Florida 32610-0236, USA. ihtsham.haq@neurology.ufl.edu
Journal
Expert Opin Pharmacother. 2007 Nov;8(16):2799-809.
Abstract URL
Click here to view abstract

7. The future of cell therapies in the treatment of Parkinson's disease.

Author
Goya RL; Kuan WL; Barker RA;
Institution
Cambridge Centre for Brain Repair, Forvie Site, Robinson Way, Cambridge CB2 2PY, UK. rl342@cam.ac.uk
Journal
Expert Opin Biol Ther. 2007 Oct;7(10):1487-98.
Abstract URL
Click here to view abstract

8. Motor complications in Parkinson disease: clinical manifestations and management.

Author
Bhidayasiri R; Truong DD;
Institution
Chulalongkorn Comprehensive Movement Disorders Center, Division of Neurology, Chulalongkorn University Hospital, Bangkok 10330, Thailand. rbh1@ucla.edu
Journal
J Neurol Sci. 2008 Mar 15;266(1-2):204-15. Epub 2007 Sep 27.
Abstract URL
Click here to view abstract

9. Assessment of the progression of Parkinson's disease: a metabolic network approach.

Author
Eckert T; Tang C; Eidelberg D;
Institution
Center for Neurosciences, Feinstein Institute for Medical Research, North Shore-Long Island Jewish Health System, Manhasset, NY 11030, USA.
Journal
Lancet Neurol. 2007 Oct;6(10):926-32.
Abstract URL
Click here to view abstract

10. Zonisamide for the treatment of Parkinson's disease.

Author
Miwa H;
Institution
Wakayama Medical University, Department of Neurology, 811-1 Kimiidera, Wakayama city, Wakayama 641-8510, Japan. h-miwa@wakayama-med.ac.jp
Journal
Expert Rev Neurother. 2007 Sep;7(9):1077-83.
Abstract URL
Click here to view abstract
Pages: 1 2 3 4 5 6 7 8 9 10